Platelet-rich plasma for rotator cuff repair

Area of Science:

• Orthopedic Surgery
• Regenerative Medicine
• Biomaterials Science

Background:

• Rotator cuff tears are a frequent cause of shoulder pain and disability, often resulting from combined traumatic and degenerative factors.
• Surgical repair of rotator cuff tears is complex, with a significant risk of retears despite intervention.
• Risk factors for retears include patient age, tear size, number of tendons involved, and smoking.

Purpose of the Study:

• To evaluate the potential of Platelet-Rich Plasma (PRP) in augmenting rotator cuff tendon healing.
• To investigate the influence of PRP composition, particularly leukocyte levels and activation methods, on healing outcomes.
• To critically assess current clinical data regarding PRP efficacy in rotator cuff repair.

Main Methods:

• Review and analysis of existing clinical data on PRP use in rotator cuff repair.
• Examination of PRP characteristics, including platelet concentration, leukocyte content, and activation mechanisms (e.g., thrombin activation).
• Evaluation of study parameters such as outcome measurement (clinical vs. structural integrity) and patient follow-up duration.

Main Results:

• Not all PRP formulations are equivalent; higher leukocyte levels may impede tendon healing.
• Thrombin activation's immediate growth factor release might inhibit certain healing processes.
• Clinical evidence for PRP benefit is not yet conclusive, with potential dose-dependency and varied outcome measures.

Conclusions:

• Careful evaluation of published PRP studies is necessary due to variability in PRP types and methodologies.
• The PRP fibrin matrix formulation currently shows the most promise for enhancing clinical success in rotator cuff tendon repair.
• Further research is needed to optimize PRP application and standardize outcome assessments for rotator cuff healing.